Study Links Early Smartphone Ownership Before Age 13 to Worse Mental Health Outcomes
By
donsupreme
Slow-proofed and worth the wait. Worth its weight in flour.
Summary
A study published in the Journal of Human Development and Capabilities found that children who own smartphones before age 13, particularly girls, have worse mental health outcomes as young adults. The research analyzed questionnaire results from over 100,000 young adults aged 18-24, showing associations between early smartphone ownership and increased mental health symptoms including aggression, detachment, hallucinations, and suicidal thoughts. Early smartphone use was also linked to low self-image in both girls and boys.
Key quotes
· 5 pulledChildren, especially girls, who own smartphones before they are 13 years old may have worse mental health outcomes when they're older, a new study suggests.
The study, published Sunday in the Journal of Human Development and Capabilities, analyzed self-reported questionnaire results from more than 100,000 young adults between the ages of 18 and 24.
The questionnaire asked respondents about mental health symptoms, such as having aggression, feelings of detachment, hallucinations and suicidal thoughts.
Those who were given smartphones at an earlier age were associated with worse mental health outcomes.
Early smartphone use was linked to low self-image in girls and boys.
You might also wanna read
German Researcher Decodes Newborn Cries to Study Pre-Speech Development
This article profiles Dr. Kathleen Wermke, a German researcher at Würzburg University Clinic who studies newborn cries to understand pre-spe
Singapore Study: Heavy Infant Screen Time Linked to Teen Anxiety and Brain Development Changes
A Singapore government study tracking 168 children for over a decade found that infants exposed to high screen time before age two showed br
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
